CD274 and neoplasm: Conversely, cytokine induction by Smac mimetics could enhance an anti-tumor immune response [56–58], and combinations with immune checkpoint inhibitors may be worth investigating given recent findings with nab-paclitaxel and the PD-L1 inhibitor atezolizumab in PD-L1 positive TNBC [9].